Created with Sketch.
Managed Care Cast
12 minutes | Oct 19, 2021
Can Cognitive Dissonance Help Spur Vaccine Uptake?
As the COVID-19 pandemic continues to take a toll on the nation a year-and-a-half later, public health workers, leaders, and researchers alike are still grappling with ways to convince a large swath of Americans to roll up their sleeves and get vaccinated. Even as cases and deaths decline nationally, states like Alaska continue to ration care as hospitals struggle with surges of largely unvaccinated patients with COVID-19. Currently, approximately 57% of the nation’s population is fully vaccinated, meaning at least 100 million more individuals have yet to receive the shot. For these reasons, safety precautions like masking, social distancing and encouraging vaccinations remain crucial to stamp out the virus. In a recent study published in Basic and Applied Social Psychology, researchers sought to increase compliance with coronavirus safety measures using cognitive dissonance as a guide, and their results yielded some promising conclusions. On this episode of Managed Care Cast, we speak with Logan Pearce, a graduate student at Princeton University and co-author of the study, “Fostering COVID-19 Safe Behaviors Using Cognitive Dissonance.”
10 minutes | Oct 13, 2021
Keeping Patients With Cancer Out of the ED Through Dedicated Urgent Care
For one cancer center, an outgrowth of the COVID-19 pandemic spurred plans to create an urgent care center for patients with cancer so that they could stay out of the emergency department. The Winship Cancer Institute of Emory University began planning for construction in 2020 after receiving a sizeable donation and broke ground this year. The Rollins Immediate Care Center is expected to open in 2022. On this episode of Managed Care Cast, we bring you an interview conducted by the editorial director of OncLive®, Gina Mauro, who talks with Charise Gleason, MSN, NP-BC, AOCNP, the advance practice provider chief at Winship Cancer Institute, about how having a dedicated cancer urgent care center will make cancer treatment plans seamless while also helping patients avoid exposure to infectious diseases in emergency waiting rooms.
14 minutes | Oct 5, 2021
Update on Migraine Patient Care Challenges During the Pandemic
Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with Deena E. Kuruvilla, MD, FAHS, the medical director of the Westport Headache Institute. She and Matt Hoffman, managing editor of NeurologyLive, another MJH Life Sciences medical news website, had a conversation a few weeks after this year’s American Headache Society Annual Scientific Meeting. They discuss the obstacles patients with migraine face during the pandemic to getting necessary care, the effect of worsening lifestyle changes over the past year and a half on patients with headaches, the difficulty in finding a clinician who knows about the latest migraine treatments, issues related to prior authorization, and more.
15 minutes | Sep 28, 2021
Reviewing Race and Kidney Disease in the NKF-ASN Task Force Report
Black Americans are 4 times more likely to develop kidney failure and are diagnosed with chronic kidney disease later and in later stages than White Americans. They are less likely to be deemed eligible for a transplant, instead going on dialysis. Last week a joint report from the American Society of Nephrology (ASN) and the National Kidney Foundation (NKF) recommended the removal of a racially based modifier used in calculating the estimated glomerular filtration rate, which has the effect of making Black patients seem healthier than they really are, leading to care delays. On this episode of Managed Care Cast, we speak with Susan Quaggin, MD, FASN, a nephrologist and the chief of nephrology/hypertension and director of the Feinberg Cardiovascular and Renal Research Institute at Northwestern University, as well as current president of the ASN. She discusses the recommendations of the National Kidney Foundation (NKF) and ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases and what comes next for laboratories, clinicians, and patients.
28 minutes | Sep 21, 2021
Spotlighting Pandemic-Related Challenges, Data-Driven Solutions for Payers
On this episode of Managed Care Cast, we speak with Cheryl Mason, director of Content and Informatics for the Health Language solutions team of Wolters Kluwer, who discusses how delays in routine care and other aspects of the pandemic are affecting payer organizations today, and how technology innovations like natural language processing can work to empower key initiatives in population health and beyond.
13 minutes | Sep 14, 2021
Assessing Lower-Than-Expected Health Care Utilization Trends in Early 2021
On this episode of Managed Care Cast, we speak with the lead clinician of a study by the Epic Health Research Network and Kaiser Family Foundation, which found that routine medical care and hospital admissions remained below expected levels in the early months of 2021, marking the second consecutive year for such results.
30 minutes | Sep 8, 2021
Examining the Current Lack of Trust in Health Care
Trust in health care was eroding even before the COVID-19 pandemic. In a new book, "Re-Engaging in Trust: The Missing Ingredient to Fixing Healthcare," the authors, Jan Berger, MD, MJ, the CEO of Health Intelligence Partners, and Julie Slezak, MSPH, the president of the health care consulting firm, delve into this issue with data from multiple sources and viewed against the backdrop of multiple stakeholders. Trust among stakeholders—providers, patients, health care organizations and systems, payers, drug companies, and others—is essential, yet it is increasingly fragile, they write. Trust should be measured and improved alongside health care metrics, according to Berger, who discusses the book on this episode of Managed Care Cast.
20 minutes | Aug 31, 2021
Key Issues Influencing 2022 Employer Health Care Strategy and Plan Design
With COVID-19 continuing to change the way in which health care is perceived and delivered, large employers have been tasked with managing employee health concerns in real time, while also planning for when the pandemic does subside. In the Business Group on Health’s 2022 Large Employers’ Health Care Strategy and Plan Design Survey, employers discussed their perspectives on trends in health care cost and coverage, and how these aspects will influence their benefits strategies and programs in the coming year. On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, who discussed 5 major areas of concern spotlighted by employers in the survey, which included health equity and the pandemic’s long-term impact.
29 minutes | Aug 24, 2021
Reckoning With the Repercussions of Worsening Climate Change on Health Systems
The recently released Intergovernmental Panel on Climate Change’s sixth assessment report drove home many of the concerns regarding the detrimental impacts of climate change that many have been warning about for years. But along with renewed calls for governmental action come doubts that the United States’ and other health care systems are equipped to handle such an influx of increasing medical issues wrought by climate change. Health systems and personnel have already been tested with the monumental crisis of COVID-19, and with higher rates of diseases expected from increased exposure to pollution, to more emergency responses warranted by frequent natural disasters, health professionals around the world are calling for immediate action to curb current and future ramifications. On this episode of Managed Care Cast, we speak with Laalitha Surapaneni, MD, MPH, an assistant professor of medicine at the University of Minnesota. Surapaneni discusses her work in mobilizing calls for climate action, the threat of worsened health outcomes due to climate change, and steps health systems can take to better prepare for these challenges.
10 minutes | Aug 19, 2021
Co-pay Accumulator Rule Could Cost Patients at the Pharmacy Counter
Co-pay accumulator adjustment programs, or CAAPs, can help incentivize use of lower-cost generics by excluding drug manufacturer assistance from counting toward a patient’s out-of-pocket maximum. However, a rule finalized by HHS last year allows CAAPs to be applied even when no generic alternative is available. If patients are not informed about the implications of these programs, they may be forced to abandon their prescriptions in the face of unaffordable co-pays. On this episode of Managed Care Cast, we’re talking with an author of a Commentary published in our August 2021 issue. The article, “CAAP Rule and Prescription Drug Prices,” explains the mechanisms of CAAPs and the potential consequences of the new HHS rule. Joining us today is Bryan S. Walsh, JD, of Brigham and Women’s Hospital and Harvard Medical School.
20 minutes | Aug 17, 2021
Addressing Pay-for-Delay Deals, Anticompetition in the Pharmaceutical Industry
On this episode of Managed Care Cast, we speak with Michael Abrams, managing partner at Numerof & Associates, on persistent barriers to entry for generics entering the pharmaceutical market, the impact of antitrust laws issued by the Biden administration, and further steps that are warranted to address anticompetitive tactics.
26 minutes | Aug 12, 2021
Managed Care Cast Presents: MS Stakeholder Summit—New Treatment Landscape in MS, Part 1
Today, we’re bringing you part 1 of a 2-part podcast series discussing multiple sclerosis, or MS. As part of the MS Stakeholder Summit, a panel of experts discusses tailoring treatments to patients with MS, payer considerations, and more.
27 minutes | Aug 10, 2021
Exploring 2022 Trends in Health and Hospital Drug Spending With Vizient
Vizient recently released its Summer 2021 Pharmacy Market Outlook, which projects pharmaceutical spending for 2022 based on an analysis of its members' data, and on this episode of Managed Care Cast, we talk about some of their findings. The report, which delves into its members’ purchasing patterns, predicts a 3.1% increase in pharmaceutical spending next year, with oncology drugs accounting for about 25% of the increase. The report also discusses increasing competition from biosimilars, including the recent approval of insulin glargine as an interchangeable biosimilar for the treatment of diabetes; the practice of white bagging; and other issues. On this episode of Managed Care Cast, we speak with Steven Lucio, PharmD, BCPS, senior principal, Pharmacy Solutions, about the report, which also discusses the continued impact of COVID-19 on health care.
9 minutes | Aug 3, 2021
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
August is National Psoriasis Awareness Month, and on this episode of Managed Care Cast, we bring you an excerpt of an interview conducted by Linda Stocum, assistant editor of Dermatology Times, for Medical World News, a new webcast from MJH Life Sciences. In it, Jerry Bagel, MD, MS, Windsor Dermatology, East Windsor, New Jersey, discusses how psoriasis is now understood to be an inflammatory disease that, if left intreated, can have devastating cardiovascular effects, affecting lifespan and quality of life, especially for young people. He also discusses the many lifestyle changes that some patients will need to make after their skin becomes clear.
15 minutes | Jul 27, 2021
Huntington Disease Community Regroups After Trial Failures
Huntington disease is an incurable, progressive neurodegenerative condition that is ultimately fatal, and the field of research into this rare disease saw a setback a few months ago with the end of 2 clinical trials for a type of possible therapy from Roche and Wave Life Sciences. On this episode of Managed Care Cast, we bring you an excerpt of an interview, originally conducted by Matt Hoffman, senior editor of NeurologyLive, with Daniel Claassen, MD, MS, director, Huntington’s Disease Clinic, and division chief, of Behavioral and Cognitive Neurology, Vanderbilt University Medical Center. Claassen reviews the trial terminations and what that means for patients with this disease, but he also reviews some other candidates in the pharmaceutical pipeline, as well as the need for patient-reported outcomes and the possibility of wearable sensors.
18 minutes | Jul 20, 2021
In Most of the US, Self-insured Employers Lack Power at the Bargaining Table With Hospitals
In this episode of Managed Care Cast, the lead author of an article in the July issue of The American Journal of Managed Care® describes the latest research that looks at the power of self-insured employers to negotiate hospital prices and the relationship between employer market power and hospital prices. Matthew Eisenberg, PhD, and coauthors used the US Census Bureau County Business Patterns data from 2010 to 2016 to estimate employer market power in metropolitan statistical areas (MSAs) and used Truven Health MarketScan commercial claims to estimate mean hospital prices and price ratios at the MSA level. The paper, "Large Self-insured Employers Lack Power to Effectively Negotiate Hospital Prices," notes a few alternative ways that employers have tried to increase their ability to raise their purchasing power, but the success has been limited. Eisenberg, an economist and assistant professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, joined Managed Care Cast to discuss these findings.
14 minutes | Jul 13, 2021
Is Private Health Insurance Really Superior to Public Programs?
In a recent paper published in JAMA Network Open, Charlie Wray, DO, MS, and colleagues examined experiences and opinions of nearly 150,000 Americans representing the 5 major forms of health insurance coverage. Specifically, the researchers used survey data from the 2016-2018 Behavioral Risk Factor Surveillance System and compared access to care, cost of care, and reported satisfaction among those with public or private insurance. Representing the experiences of over 61 million US adults, respondents included Medicaid and Medicare beneficiaries, those with Veterans Health Administration or military coverage, and those with individually purchased and employer-sponsored coverage. On this episode of Managed Care Cast, Wray, an assistant professor of medicine at the University of California San Francisco, describes the surprising findings of the teams’ analyses, and offers some solutions to improving the quality of health insurance coverage in the United States.
8 minutes | Jul 6, 2021
Quelling COVID-19 Also Capped Clostridium difficile—Will It Continue?
Social distancing, vigilant sanitizing, and mask wearing required by COVID-19 did more than combat the pandemic—it cut down on flu cases as well as improved respiratory health for some patients. Some studies indicate that the measures also reduced Clostridium difficile, or C difficile, in hospitals and facilities. A recent set of interviews on Medical World News®, the 24-hour online news program for health care professionals from MJH Life Sciences™, highlighted this development. The interviews, discussing the prospect of these mitigation efforts continuing post pandemic, were conducted by one of our sister sites, HCPLive®, which covered the Digestive Disease Week meeting this spring. This episode of Managed Care Cast features a few of those interviews: Christie Teigland, PhD, vice president of Advanced Analytics for Avalere Health; Alpesh N. Amin, MD, University of California Irvine School of Medicine; and Brian E. Lacy, MD, PhD, Mayo Clinic.
28 minutes | Jun 29, 2021
Managed Care Cast Presents: MS Stakeholder Summit— New Treatment Landscape in MS, Part 2
Today, we’re bringing you part 2 of the MS Stakeholder Summit series. During part 1, which first ran 2 weeks ago, a panel of experts discussed tailoring treatments to patients with multiple sclerosis, payer considerations, and more. In this second part of the series, the same panel of experts continues their talk on MS. They will discuss newer therapies, switching therapies, and more.
19 minutes | Jun 29, 2021
Reports Highlight Strengthening Primary Care After the Pandemic
Linda Schwimmer, JD, president and CEO of the New Jersey Health Care Quality Institute, discusses 2 reports on strengthening primary care after the COVID-19 pandemic: one from her own organization and the other from the National Academy of Medicine.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2021